Elon Musk Advocates for Prescription Ketamine Use, Asserts It's in Tesla Investors' Interest

In a series of recent interviews, Elon Musk, the CEO of Tesla and SpaceX, has openly discussed his prescribed use of ketamine, suggesting that it not only aids his mental health but also benefits Tesla investors. Musk's candid revelations come amid scrutiny over his behavior and its potential impact on his companies.

During an interview with former CNN anchor Don Lemon, Musk detailed his ketamine usage, explaining that he takes a "small amount once every other week" to manage what he describes as a "negative chemical state" in his brain, akin to depression. Musk emphasized that this regimen helps him maintain a positive frame of mind, crucial for his extensive work responsibilities.

Musk's comments have sparked a broader conversation about mental health and drug use among high-profile executives. He defended his ketamine use by highlighting its effectiveness in keeping him productive and focused, which he argues is directly linked to Tesla's success. "From the standpoint of Wall Street, what matters is execution," Musk stated, adding that his ability to lead Tesla to become one of the most valuable car manufacturers globally justifies his continued use of the drug.

The entrepreneur's drug use has previously raised concerns among investors and corporate boards, particularly regarding potential violations of federal policies that could jeopardize government contracts, especially with SpaceX's dealings with NASA. However, Musk reassured that his consumption of the drug has not negatively affected his business ventures. In fact, he underwent random drug testing for three years at NASA's request, with no trace amounts of drugs or alcohol found.

Musk's advocacy for ketamine as a treatment for depression contrasts with his criticism of other antidepressants, such as SSRIs, which he has described as "zombifying." His openness about using ketamine, a drug that has gained attention as a potential alternative therapy for depression and anxiety, reflects a growing interest in exploring unconventional treatments for mental health issues.

Despite the controversy, Musk remains steadfast in his belief that his ketamine use is beneficial not only for his personal health but also for Tesla's investors. His stance has reignited discussions about mental health care, the stigma surrounding drug use, and the pressures faced by individuals in high-stakes leadership positions.

As the conversation unfolds, Musk's transparency about his mental health struggles and treatment choices may encourage a more open dialogue about these issues in the corporate world and beyond.